0001127602-19-010115.txt : 20190305 0001127602-19-010115.hdr.sgml : 20190305 20190305194839 ACCESSION NUMBER: 0001127602-19-010115 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190215 FILED AS OF DATE: 20190305 DATE AS OF CHANGE: 20190305 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Alton Gregg H CENTRAL INDEX KEY: 0001334682 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19731 FILM NUMBER: 19660799 MAIL ADDRESS: STREET 1: 333 LAKESIDE DRIVE CITY: FOSTER CITY STATE: CA ZIP: 94404 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GILEAD SCIENCES INC CENTRAL INDEX KEY: 0000882095 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943047598 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 333 LAKESIDE DR CITY: FOSTER CITY STATE: CA ZIP: 94404 BUSINESS PHONE: 6505743000 MAIL ADDRESS: STREET 1: 333 LAKESIDE DR CITY: FOSTER CITY STATE: CA ZIP: 94404 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2019-02-15 0000882095 GILEAD SCIENCES INC GILD 0001334682 Alton Gregg H GILEAD SCIENCES, INC. 333 LAKESIDE DRIVE FOSTER CITY CA 94404 1 Chief Patient Officer Common Stock 2019-02-15 5 A 0 E 330 57.4515 A 58046 D Non-qualified Stock Option (Right to Buy) 66.01 2019-03-01 4 A 0 9640 0 A 2029-03-01 Common Stock 9640 9640 D Restricted Stock Unit 2019-03-01 4 A 0 1890 0 A Common Stock 1890 15530 D Shares were acquired under the Gilead Sciences, Inc. Employee Stock Purchase Plan. The options have a four year vesting schedule. 25% of the options will vest on the first anniversary date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested. Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. The restricted stock units have a four year vesting schedule. 25% vest on the anniversary of the date of grant until fully vested. /s/ Marissa Song by Power of Attorney for Gregg H. Alton 2019-03-05